Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Colorectal Neoplasms

  Free Subscription


Articles published in J Surg Oncol

Retrieve available abstracts of 210 articles:
HTML format



Single Articles


    July 2021
  1. ZHANG LM, Schuitevoerder D, White MG, Feldt S, et al
    Combined mechanical and oral antibiotic bowel preparation is associated with prolonged recurrence-free survival following surgery for colorectal cancer.
    J Surg Oncol. 2021 Jul 26. doi: 10.1002/jso.26619.
    PubMed     Abstract available


  2. LWIN TM, Turner MA, Amirfakhri S, Nishino H, et al
    Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.
    J Surg Oncol. 2021 Jul 26. doi: 10.1002/jso.26623.
    PubMed     Abstract available


  3. TODATE Y, Honda M, Takada T, Saginoya T, et al
    The additional diagnostic impact of positron emission tomography-computed tomography for lymph node metastasis from colorectal cancer: A prospective lymph node level analysis.
    J Surg Oncol. 2021 Jul 14. doi: 10.1002/jso.26602.
    PubMed     Abstract available


  4. DIAZ A, Dalmacy D, Hyer JM, Tsilimigras D, et al
    Intersection of social vulnerability and residential diversity: Postoperative outcomes following resection of lung and colon cancer.
    J Surg Oncol. 2021 Jul 1. doi: 10.1002/jso.26588.
    PubMed     Abstract available


    June 2021
  5. PATEL S, Sukumar V, Kazi M, Saklani A, et al
    Safety and feasibility of sphincter preservation surgery in low lying rectal cancers.
    J Surg Oncol. 2021;123:1651-1652.
    PubMed    


  6. DREFS M, Schoenberg MB, Schiergens TS, Albertsmeier M, et al
    Chances, challenges and outcomes of patients with complex bilobar colorectal liver metastases approached by a combined multimodal therapy with liver resection and local ablative therapy.
    J Surg Oncol. 2021;123:1578-1591.
    PubMed     Abstract available


    May 2021
  7. SUGARBAKER PH, Deng T, Chang D
    Peritoneal cytology as an indicator of peritoneal metastases in colorectal cancer.
    J Surg Oncol. 2021 May 7. doi: 10.1002/jso.26520.
    PubMed     Abstract available


  8. JIANG TY, Zang L, Dong F, Feng B, et al
    Effect of different reinforcement methods on anastomotic leakage prevention after laparoscopic double anastomosis.
    J Surg Oncol. 2021;123 Suppl 1:S81-S87.
    PubMed     Abstract available


  9. LI R, Shen K, Wang Z, Xie Z, et al
    Short-term outcomes of medium-low rectal cancer treated by taTME and experience of 22 cases.
    J Surg Oncol. 2021;123 Suppl 1:S52-S58.
    PubMed     Abstract available


  10. FENG W, Zong Y, Zhao J, Li W, et al
    High versus low ligation of the inferior mesenteric artery during laparoscopic rectal cancer surgery: A prospective study of surgical and oncological outcomes.
    J Surg Oncol. 2021;123 Suppl 1:S76-S80.
    PubMed     Abstract available


  11. JIANG TY, Ma JJ, Zheng MH
    Controversies and consensus in transanal total mesorectal excision (taTME): Is it a valid choice for rectal cancer?
    J Surg Oncol. 2021;123 Suppl 1:S59-S64.
    PubMed     Abstract available


  12. ZHAO X, Ma J, Fu Z, Hong H, et al
    Prognostic value of apical lymph node metastasis at the inferior mesenteric artery in sigmoid and rectal cancer patients who undergo laparoscopic surgery.
    J Surg Oncol. 2021;123 Suppl 1:S88-S94.
    PubMed     Abstract available


  13. XIAO Y, Lin C, Lu JY, Xu L, et al
    Short-term outcomes of pure transvaginal laparoscopic right colectomy: A novel surgery approach based on an Idea, Development, Exploration, Assessment, Long-term framework stage IIa study.
    J Surg Oncol. 2021;123 Suppl 1:S36-S42.
    PubMed     Abstract available


  14. AN YB, Yao HW, Yang XH, Zhang X, et al
    Verification of data in a nationwide transanal total mesorectal excision registry in China.
    J Surg Oncol. 2021;123 Suppl 1:S43-S51.
    PubMed     Abstract available


  15. HONG HJ, Zhao X, Yu CR, Sun J, et al
    Comparative study of oncologic efficacy of cephalomedial to lateral dissection versus medial to lateral dissection in laparoscopic total mesorectal excision for rectal cancer: An RCT study.
    J Surg Oncol. 2021;123 Suppl 1:S65-S75.
    PubMed     Abstract available


  16. BOHLOK A, Duran Derijckere I, Azema H, Lucidi V, et al
    Clinico-metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases.
    J Surg Oncol. 2021;123:1773-1783.
    PubMed     Abstract available


  17. KAZI M, Bhamre R, DeSouza A, Ostwal V, et al
    Long-term oncological outcomes of the sphincter preserving total mesorectal excision with varying distal resection margins.
    J Surg Oncol. 2021;123:1784-1791.
    PubMed     Abstract available


    April 2021
  18. OZAWA T, Matsuda K, Ishihara S, Fukushima Y, et al
    The robust performance of carcinoembryonic antigen levels after adjuvant chemotherapy for the recurrence risk stratification in patients with colorectal cancer.
    J Surg Oncol. 2021 Apr 13. doi: 10.1002/jso.26497.
    PubMed     Abstract available


  19. BEHRENBRUCH C, Prabhakaran S, Udayasiri D D, Michael M, et al
    Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study.
    J Surg Oncol. 2021;123:1263-1273.
    PubMed     Abstract available


    March 2021
  20. LYNCH KT, Kane WJ, Fleming MA, Desai RP, et al
    Childhood cancer survivors face markedly worse overall survival after diagnosis with breast cancer, melanoma, or colorectal cancer.
    J Surg Oncol. 2021 Mar 31. doi: 10.1002/jso.26478.
    PubMed     Abstract available


  21. LEIPHRAKPAM PD, Lazenby AJ, Smith LM, Brattain MG, et al
    Stathmin expression in metastatic colorectal cancer.
    J Surg Oncol. 2021 Mar 25. doi: 10.1002/jso.26464.
    PubMed     Abstract available


  22. FELDMAN HA, Zhou N, Antonoff MB, Hofstetter WL, et al
    Simultaneous versus staged resections for bilateral pulmonary metastases.
    J Surg Oncol. 2021 Mar 8. doi: 10.1002/jso.26392.
    PubMed     Abstract available


  23. LUMISH MA, Cercek A
    Immunotherapy for the treatment of colorectal cancer.
    J Surg Oncol. 2021;123:760-774.
    PubMed     Abstract available


  24. SUN Y, Zhang D, Feng Y, Wang Y, et al
    Infrapyloric lymph node dissection in right hemicolectomy for colon cancer: Should prophylactic resection be recommended?
    J Surg Oncol. 2021 Mar 1. doi: 10.1002/jso.26388.
    PubMed     Abstract available


  25. GRASS F, Merchea A, Mathis KL, Mishra N, et al
    Cost drivers of locally advanced rectal cancer treatment-An analysis of a leading healthcare insurer.
    J Surg Oncol. 2021;123:1023-1029.
    PubMed     Abstract available


  26. DENADAI MVA, Melani AGF, Neto MC, Romagnolo LGC, et al
    Robotic rectal surgery: Outcomes of the first 102 totally robotic cases handled using the single-docking technique in a reference institution.
    J Surg Oncol. 2021;123:997-1004.
    PubMed     Abstract available


    February 2021
  27. WILLIAMS AD, Sun T, Kakade S, Wong SL, et al
    Comparison of open and minimally invasive approaches to colon cancer resection in compliance with 12 regional lymph node harvest quality measure.
    J Surg Oncol. 2021 Feb 12. doi: 10.1002/jso.26298.
    PubMed     Abstract available


  28. LE VH, Thornblade L, Ituarte PHG, Lai LL, et al
    Metachronous peritoneal metastases following curative resection for colon cancer: Understanding risk factors and patterns of recurrence.
    J Surg Oncol. 2021;123:622-629.
    PubMed     Abstract available


  29. MURPHY C, Stephens I, OFlanagan G, OByrne L, et al
    A comparison of oncological outcomes after abdominoperineal excision before and after the implementation of a selective perineal flap closure program.
    J Surg Oncol. 2021;123:614-621.
    PubMed     Abstract available


    January 2021
  30. ISHIMARU K, Kawai K, Nozawa H, Sasaki K, et al
    Hazard function analysis of metastatic recurrence after colorectal cancer surgery-A nationwide retrospective study.
    J Surg Oncol. 2021 Jan 14. doi: 10.1002/jso.26378.
    PubMed     Abstract available


  31. KAMPHUES C, Andreatos N, Kruppa J, Buettner S, et al
    The optimal cut-off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi-institutional study.
    J Surg Oncol. 2021 Jan 5. doi: 10.1002/jso.26361.
    PubMed     Abstract available


  32. DE NARDI P, Mistrangelo M, Burtulo G, Passoni P, et al
    Tailoring the radiotherapy approach in patients with anal squamous cell carcinoma based on inguinal sentinel lymph node biopsy.
    J Surg Oncol. 2021;123:315-321.
    PubMed     Abstract available


  33. LEIPHRAKPAM PD, Chowdhury S, Wang J, Black JD, et al
    The role and therapeutic implications of PI3K signaling pathway in cancer.
    J Surg Oncol. 2021;123:39-41.
    PubMed    


  34. EL ASMAR A, Veys I, Larsimont D, Donckier V, et al
    Inferior epigastric artery lymph nodes: A pathway for systemic dissemination from peritoneal carcinomatosis?
    J Surg Oncol. 2021;123:311-314.
    PubMed     Abstract available


  35. ROUANET P, Rivoire M, Gourgou S, Lelong B, et al
    Sphincter-saving surgery for ultra-low rectal carcinoma initially indicated for abdominoperineal resection: Is it safe on a long-term follow-up?
    J Surg Oncol. 2021;123:299-310.
    PubMed     Abstract available


  36. MUADDI H, D'Angelica M, Wiseman JT, Dillhoff M, et al
    Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.
    J Surg Oncol. 2021;123:252-260.
    PubMed     Abstract available


  37. CHUAN L, Linfeng G, Hongchang L, Xiaosong W, et al
    Short-term outcomes of pelvic floor peritoneum closure in endoscopic low anterior resection of rectal cancer: A propensity score matching analysis.
    J Surg Oncol. 2021;123:271-277.
    PubMed     Abstract available


  38. SELL NM, Qwaider YZ, Goldstone RN, Cauley CE, et al
    Ten-year survival after pathologic complete response in rectal adenocarcinoma.
    J Surg Oncol. 2021;123:293-298.
    PubMed     Abstract available


  39. KOIZUMI M, Yamada T, Shinji S, Matsuda A, et al
    Even a partial pathological response is associated with lower relapse rates in patients with operable rectal cancer undergoing neoadjuvant chemotherapy.
    J Surg Oncol. 2021;123:286-292.
    PubMed     Abstract available


  40. ZHOU P, Goffredo P, Ginader T, Thompson D, et al
    Impact of KRAS status on tumor response and survival after neoadjuvant treatment of locally advanced rectal cancer.
    J Surg Oncol. 2021;123:278-285.
    PubMed     Abstract available


  41. LEE RM, Gamboa AC, Turgeon MK, Zaidi MY, et al
    A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC.
    J Surg Oncol. 2021;123:187-195.
    PubMed     Abstract available


  42. MCKENNA NP, Bews KA, Colibaseanu DT, Mathis KL, et al
    The intersection of tumor location and combined bowel preparation: Utilization differs but anastomotic leak risk reduction does not.
    J Surg Oncol. 2021;123:261-270.
    PubMed     Abstract available


    December 2020
  43. KAMPHUES C, Kadowaki S, Amini N, van den Berg I, et al
    The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: An international, multi-institutional study in patients with known KRAS, BRAF, and MSI status.
    J Surg Oncol. 2020 Dec 23. doi: 10.1002/jso.26352.
    PubMed     Abstract available


  44. PARK YY, Lee J, Han YD, Cho MS, et al
    Survival outcomes after isolated local recurrence of rectal cancer and risk analysis affecting its resectability.
    J Surg Oncol. 2020;122:1470-1480.
    PubMed     Abstract available


  45. BENOIT O, Svrcek M, Creavin B, Bouquot M, et al
    Prognostic value of tumor deposits in rectal cancer: A monocentric series of 505 patients.
    J Surg Oncol. 2020;122:1481-1489.
    PubMed     Abstract available


  46. SROUJI RM, Narayan RR, Boerner T, Buisman FE, et al
    Extrahepatic recurrence rates in patients receiving adjuvant hepatic artery infusion and systemic chemotherapy after complete resection of colorectal liver metastases.
    J Surg Oncol. 2020;122:1536-1542.
    PubMed     Abstract available


  47. SAKAMOTO T, Hida K, Hoshino N, Yamaguchi T, et al
    Changes in the sexual function of male patients with rectal cancer over a 2-year period from diagnosis to 24-month follow-up: A prospective, multicenter, cohort study.
    J Surg Oncol. 2020;122:1647-1654.
    PubMed     Abstract available


  48. VASAN K, Anand S, Satgunaseelan L, Asher R, et al
    Mismatch repair protein loss in cutaneous head and neck squamous cell carcinoma.
    J Surg Oncol. 2020;122:1755-1760.
    PubMed     Abstract available


    November 2020
  49. PATA G, Bianchetti L, Rota M, Marengoni A, et al
    Multidimensional Prognostic Index (MPI) score has the major impact on outcome prediction in elderly surgical patients with colorectal cancer: The FRAGIS study.
    J Surg Oncol. 2020 Nov 25. doi: 10.1002/jso.26314.
    PubMed     Abstract available


  50. LEIPHRAKPAM PD, Lazenby AJ, Smith LM, Brattain MG, et al
    Correlation of PRL3 expression with colorectal cancer progression.
    J Surg Oncol. 2020 Nov 12. doi: 10.1002/jso.26253.
    PubMed     Abstract available


  51. AZIN A, Hirpara DH, Draginov A, Khorasani M, et al
    Adequacy of lymph node harvest following colectomy for obstructed and nonobstructed colon cancer.
    J Surg Oncol. 2020 Nov 3. doi: 10.1002/jso.26274.
    PubMed     Abstract available


  52. AUGUSTIN T, Moslim MA, Cengiz TB, El-Hayek K, et al
    Survival outcomes after surgical management of sporadic or familial adenomatous polyposis associated duodenal cancer.
    J Surg Oncol. 2020;122:1132-1144.
    PubMed     Abstract available


  53. GIESEN LJX, Borstlap WAA, Bemelman WA, Tanis PJ, et al
    Effect of understaging on local recurrence of rectal cancer.
    J Surg Oncol. 2020;122:1179-1186.
    PubMed     Abstract available


    October 2020
  54. ALESE OB, Zakka K, Huo X, Jiang R, et al
    Perioperative therapy in metastatic colorectal cancer: Pattern of use and survival outcomes.
    J Surg Oncol. 2020 Oct 30. doi: 10.1002/jso.26278.
    PubMed     Abstract available


  55. SUAREZ J, Mata E, Guerra A, Jimenez G, et al
    Impact of the COVID-19 pandemic during Spain's state of emergency on the diagnosis of colorectal cancer.
    J Surg Oncol. 2020 Oct 19. doi: 10.1002/jso.26263.
    PubMed     Abstract available


  56. HAMID HKS
    Considerations for transanal surgery during COVID-19 pandemic.
    J Surg Oncol. 2020;122:995.
    PubMed    


  57. DE CRIGNIS L, Slim K, Cotte E, Meillat H, et al
    Impact of surgical indication on patient outcomes and compliance with enhanced recovery program for colorectal surgery: A Francophone multicenter retrospective analysis.
    J Surg Oncol. 2020;122:928-933.
    PubMed     Abstract available


  58. NICHOLS DS, Satteson E, Harbor P, DeFranzo A, et al
    Factors associated with the use of vertical rectus abdominus myocutaneous flap reconstruction following abdominoperineal resection for anorectal cancer.
    J Surg Oncol. 2020;122:923-927.
    PubMed     Abstract available


    September 2020
  59. RAOOF M, Fong Y
    Liver resection for colorectal cancer liver metastases: An often-neglected opportunity for cure.
    J Surg Oncol. 2020 Sep 24. doi: 10.1002/jso.26192.
    PubMed    


  60. RAJ KUMAR B, Pandey D, Rohila J, deSouza A, et al
    An observational study of the demographic and treatment changes in a tertiary colorectal cancer center during the COVID-19 pandemic.
    J Surg Oncol. 2020 Sep 3. doi: 10.1002/jso.26193.
    PubMed     Abstract available


  61. KAWAKATSU S, Mise Y, Hiratsuka M, Inoue Y, et al
    Clinical significance of subcentimeter pulmonary nodules in patients undergoing hepatectomy for colorectal liver metastases.
    J Surg Oncol. 2020;122:523-528.
    PubMed     Abstract available


    August 2020
  62. PARK Y, Kim DW, Hong YJ, Park KU, et al
    Is elevated microsatellite alterations at selected tetranucleotide repeats (EMAST)-negative/MSI-high colorectal cancer a distinct subtype of the disease?
    J Surg Oncol. 2020 Aug 10. doi: 10.1002/jso.26157.
    PubMed     Abstract available


  63. SEBASTIAN-TOMAS JC, Domingo-Del Pozo C, Gomez-Abril SA, Navarro-Martinez S, et al
    Laparoscopic staged colon-first resection for metastatic colorectal cancer: Perioperative and midterm outcomes from a single-center experience.
    J Surg Oncol. 2020 Aug 10. doi: 10.1002/jso.26152.
    PubMed     Abstract available


  64. BELLI F, Sorrentino L, Gallino G, Gronchi A, et al
    A proposal of an updated classification for pelvic relapses of rectal cancer to guide surgical decision-making.
    J Surg Oncol. 2020;122:350-359.
    PubMed     Abstract available


  65. FERNANDEZ-MORENO MC, Dorcaratto D, Garces-Albir M, Munoz E, et al
    Impact of type and severity of postoperative complications on long-term outcomes after colorectal liver metastases resection.
    J Surg Oncol. 2020;122:212-225.
    PubMed     Abstract available


    July 2020
  66. BEDNARSKI BK
    Minimally invasive rectal surgery: Laparoscopy, robotics, and transanal approaches.
    J Surg Oncol. 2020;122:78-84.
    PubMed    


  67. THIELS CA, D'Angelica MI
    Hepatic artery infusion pumps.
    J Surg Oncol. 2020;122:70-77.
    PubMed     Abstract available


    June 2020
  68. BINGMER K, Ofshteyn A, Bliggenstorfer JT, Kethman W, et al
    Primary tumor location impacts survival in colorectal cancer patients after resection of liver metastases.
    J Surg Oncol. 2020 Jun 10. doi: 10.1002/jso.26061.
    PubMed     Abstract available


  69. BINGMER K, Kondray V, Ofshteyn A, Bliggenstorfer JT, et al
    Sarcopenia is associated with worse overall survival in patients with anal squamous cell cancer.
    J Surg Oncol. 2020;121:1148-1153.
    PubMed     Abstract available


  70. YANG J, Chen Q, Jindou L, Cheng Y, et al
    The influence of anastomotic leakage for rectal cancer oncologic outcome: A systematic review and meta-analysis.
    J Surg Oncol. 2020;121:1283-1297.
    PubMed     Abstract available


  71. SROUJI R, Narayan R, Boerner T, Buisman F, et al
    Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver-related mortality.
    J Surg Oncol. 2020;121:1314-1319.
    PubMed     Abstract available


  72. STEIN MK, Williard FW, Xiu J, Tsao MW, et al
    Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma.
    J Surg Oncol. 2020;121:1320-1328.
    PubMed     Abstract available


    May 2020
  73. SORRENTINO L, Guaglio M, Cosimelli M
    Elective colorectal cancer surgery at the oncologic hub of Lombardy inside a pandemic COVID-19 area.
    J Surg Oncol. 2020 May 31. doi: 10.1002/jso.26052.
    PubMed    


  74. RUEFF J, Weixler B, Viehl CT, Ochsner A, et al
    Improved quality of colon cancer surveillance after implementation of a personalized surveillance schedule.
    J Surg Oncol. 2020 May 14. doi: 10.1002/jso.25973.
    PubMed     Abstract available


  75. FIELDS AC, Lu PW, Yoo J, Irani J, et al
    Treatment of stage I-III rectal cancer: Who is refusing surgery?
    J Surg Oncol. 2020;121:990-1000.
    PubMed     Abstract available


    April 2020
  76. MIYAMOTO Y, Hiyoshi Y, Tokunaga R, Akiyama T, et al
    Postoperative complications are associated with poor survival outcome after curative resection for colorectal cancer: A propensity-score analysis.
    J Surg Oncol. 2020 Apr 28. doi: 10.1002/jso.25961.
    PubMed     Abstract available


  77. VAZ DA SILVA DG, Ribeiro HSC, Arra DASM, Torres SM, et al
    Predictors of long-term survival in patients with hepatic resection of colorectal metastases: Analysis of a Brazilian Cancer Center Cohort.
    J Surg Oncol. 2020;121:893-900.
    PubMed     Abstract available


  78. ARAUJO RLC, Sanctis MA, Barroti LC, Coelho TRV, et al
    Robotic approach as a valid strategy to improve the access to posterosuperior hepatic segments-Case series and review of literature.
    J Surg Oncol. 2020;121:873-880.
    PubMed     Abstract available


  79. RIBEIRO R, Fontes Cintra G, Barrozo A, Tieko Tsunoda A, et al
    Brazilian Society of Surgical Oncology guidelines for surgical treatment of endometrial cancer in regions with limited resources.
    J Surg Oncol. 2020;121:730-742.
    PubMed     Abstract available


  80. ARAUJO RLC, Milani JM, Armentano DP, Moreira RB, et al
    Disappearing colorectal liver metastases: Strategies for the management of patients achieving a radiographic complete response after systemic chemotherapy.
    J Surg Oncol. 2020;121:848-856.
    PubMed     Abstract available


  81. WOESTE MR, Philips P, Egger ME, Scoggins CR, et al
    Optimal perfusion chemotherapy: A prospective comparison of mitomycin C and oxaliplatin for hyperthermic intraperitoneal chemotherapy in metastatic colon cancer.
    J Surg Oncol. 2020 Apr 1. doi: 10.1002/jso.25920.
    PubMed     Abstract available


    March 2020
  82. LU PW, Fields AC, Yoo J, Irani J, et al
    Sociodemographic predictors of surgery refusal in patients with stage I-III colon cancer.
    J Surg Oncol. 2020 Mar 29. doi: 10.1002/jso.25917.
    PubMed     Abstract available


  83. YUCE TK, Ellis RJ, Chung J, Merkow RP, et al
    Association between surgical approach and survival following resection of abdominopelvic malignancies.
    J Surg Oncol. 2020;121:620-629.
    PubMed     Abstract available


    February 2020
  84. CORSINI EM, Datar SS, Mitchell KG, Zhou N, et al
    High mutational concordance between primary colorectal tumors and associated pulmonary metastases.
    J Surg Oncol. 2020 Feb 19. doi: 10.1002/jso.25871.
    PubMed     Abstract available


  85. SERRANO PE, Gu CS, Moulton CA, Husien M, et al
    Effect of PET-CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long-term results of a randomized controlled trial.
    J Surg Oncol. 2020 Feb 7. doi: 10.1002/jso.25864.
    PubMed     Abstract available


    December 2019
  86. LEIPHRAKPAM PD, Lazenby AJ, Chowdhury S, Smith LM, et al
    Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer.
    J Surg Oncol. 2019 Dec 22. doi: 10.1002/jso.25805.
    PubMed     Abstract available


  87. LIMA PMA, Torres LC, Martins MR, da Matta MC, et al
    Soluble levels of sCD40L and s4-1BB are associated with a poor prognosis in elderly patients with colorectal cancer.
    J Surg Oncol. 2019 Dec 19. doi: 10.1002/jso.25813.
    PubMed     Abstract available


  88. GOFFREDO P, Zhou P, Ginader T, Hrabe J, et al
    Positive circumferential resection margins following locally advanced colon cancer surgery: Risk factors and survival impact.
    J Surg Oncol. 2019 Dec 18. doi: 10.1002/jso.25801.
    PubMed     Abstract available


  89. GKEKAS I, Novotny J, Fabian P, Nemecek R, et al
    Mismatch repair status predicts survival after adjuvant treatment in stage II colon cancer patients.
    J Surg Oncol. 2019 Dec 11. doi: 10.1002/jso.25798.
    PubMed     Abstract available


  90. FIELDS AC, Welten VM, Lu P, Goldberg JE, et al
    Does race impact survival for patients with anal squamous cell carcinoma?
    J Surg Oncol. 2019;120:1201-1207.
    PubMed     Abstract available


  91. YANG L, Bao J, Jiang Q, Yu DS, et al
    Lower fecal pH may be a novel indicator of pouchitis after IPAA in patients with FAP or metachronous Lynch syndrome.
    J Surg Oncol. 2019;120:1184-1189.
    PubMed     Abstract available


  92. REYNOLDS IS, O'Connell E, Fichtner M, McNamara DA, et al
    Mucinous adenocarcinoma of the colon and rectum: A genomic analysis.
    J Surg Oncol. 2019;120:1427-1435.
    PubMed     Abstract available


  93. KIM JC, Lee JL, Kim CW, Lim SB, et al
    Mechanotechnical faults and particular issues of anastomotic complications following robot-assisted anterior resection in 968 rectal cancer patients.
    J Surg Oncol. 2019;120:1436-1445.
    PubMed     Abstract available


  94. XIAO C, Zhou M, Yang X, Xiao F, et al
    Novel nomogram with microvascular density in the surgical margins can accurately predict the risk for anastomotic leakage after anterior resection for rectal cancer.
    J Surg Oncol. 2019;120:1412-1419.
    PubMed     Abstract available


    November 2019
  95. SHARMA A, Alatise OI, Adisa AO, Arowolo OA, et al
    Treatment of colorectal cancer in Sub-Saharan Africa: Results from a prospective Nigerian hospital registry.
    J Surg Oncol. 2019 Nov 19. doi: 10.1002/jso.25768.
    PubMed     Abstract available


  96. MACARI D, Kawak S, Raofi V, Wasvary H, et al
    Recurrence pattern and outcomes in T4 colon cancer: A single institution analysis.
    J Surg Oncol. 2019 Nov 14. doi: 10.1002/jso.25766.
    PubMed     Abstract available


  97. GAMBOA AC, Liu Y, Lee RM, Zaidi MY, et al
    A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique.
    J Surg Oncol. 2019;120:932-939.
    PubMed     Abstract available


  98. CORSINI EM, Mitchell KG, Antonoff MB
    Response to letter to the editor.
    J Surg Oncol. 2019;120:1051-1052.
    PubMed    


  99. POLI EC, Millis AM, Berger Y, Sherman SK, et al
    Implementation of bundled care to reduce surgical site infections after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    J Surg Oncol. 2019;120:1044-1045.
    PubMed    


    October 2019
  100. LAPORTE GA, Leguisamo NM, Gloria HCE, Azambuja DB, et al
    The role of double-strand break repair, translesion synthesis, and interstrand crosslinks in colorectal cancer progression-clinicopathological data and survival.
    J Surg Oncol. 2019 Oct 25. doi: 10.1002/jso.25737.
    PubMed     Abstract available


  101. ROLFF HC, Christensen IJ, Svendsen LB, Wilhelmsen M, et al
    The concentration of the cleaved suPAR forms in pre- and postoperative plasma samples improves the prediction of survival in colorectal cancer: A nationwide multicenter validation and discovery study.
    J Surg Oncol. 2019 Oct 23. doi: 10.1002/jso.25733.
    PubMed     Abstract available


  102. SERRANO PE, Gu CS, Husien M, Jalink D, et al
    Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases.
    J Surg Oncol. 2019 Oct 14. doi: 10.1002/jso.25735.
    PubMed     Abstract available


  103. HEALY MA, Thirumurthi S, You YN
    Screening high-risk populations for colon and rectal cancers.
    J Surg Oncol. 2019;120:858-863.
    PubMed     Abstract available


    September 2019
  104. FIELDS AC, Lu P, Goldberg J, Irani J, et al
    The role of adjuvant chemotherapy in stage II and III mucinous colon cancer.
    J Surg Oncol. 2019 Sep 19. doi: 10.1002/jso.25705.
    PubMed     Abstract available


  105. LEIJSSEN LGJ, Dinaux AM, Kunitake H, Bordeianou LG, et al
    The impact of postoperative morbidity on survival in patients with metastatic colon and rectal cancer.
    J Surg Oncol. 2019;120:460-472.
    PubMed     Abstract available


  106. GHIASLOO M, Kahya H, Van Langenhove S, Grammens J, et al
    Effect of treatment sequence on survival in stage IV rectal cancer with synchronous and potentially resectable liver metastases.
    J Surg Oncol. 2019;120:415-422.
    PubMed     Abstract available


  107. MAGUIRE LH, Geiger TM, Hardiman KM, Regenbogen SE, et al
    Surgical management of primary colonic lymphoma: Big data for a rare problem.
    J Surg Oncol. 2019;120:431-437.
    PubMed     Abstract available


  108. KYANG LS, Alzahrani NA, Valle SJ, Rahman MK, et al
    Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 cases.
    J Surg Oncol. 2019;120:794-802.
    PubMed     Abstract available


  109. STUART E, Banerjee S, de la Torre J, Wang Y, et al
    Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry.
    J Surg Oncol. 2019;120:715-721.
    PubMed     Abstract available


    August 2019
  110. CHEN B
    Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
    J Surg Oncol. 2019 Aug 26. doi: 10.1002/jso.25687.
    PubMed    


  111. SAITO G, Sadahiro S, Ogimi T, Miyakita H, et al
    Preventive effects of a synthetic absorbable antiadhesive film (seprafilm) on small bowel obstruction in patients who underwent elective surgery for colon cancer: A randomized controlled trial.
    J Surg Oncol. 2019 Aug 7. doi: 10.1002/jso.25664.
    PubMed     Abstract available


  112. HUGHES BD, Hancock KJ, Shan Y, Thakker RA, et al
    Cost of benign versus oncologic colon resection among fee-for-service Medicare enrollees.
    J Surg Oncol. 2019;120:280-286.
    PubMed     Abstract available


  113. FIELDS AC, Melnitchouk N, Senturk J, Irani J, et al
    Early versus late salvage abdominoperineal resection for anal squamous cell carcinoma: Is there a difference in survival?
    J Surg Oncol. 2019;120:287-293.
    PubMed     Abstract available


  114. BAUSYS A, Kuliavas J, Dulskas A, Kryzauskas M, et al
    Early versus standard closure of temporary ileostomy in patients with rectal cancer: A randomized controlled trial.
    J Surg Oncol. 2019;120:294-299.
    PubMed     Abstract available


  115. HARDIMAN KM, Antunez AG, Kanters A, Schuman AD, et al
    Clinical and pathological outcomes of induction chemotherapy before neoadjuvant radiotherapy in locally-advanced rectal cancer.
    J Surg Oncol. 2019;120:308-315.
    PubMed     Abstract available


    July 2019
  116. DUMONT F, Munoz MA, De Franco V, Wernert R, et al
    Significance of lymph node involvement in local recurrence of colorectal cancer.
    J Surg Oncol. 2019 Jul 22. doi: 10.1002/jso.25631.
    PubMed     Abstract available


  117. CORSINI EM, Mitchell KG, Mehran RJ, Rice DC, et al
    Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
    J Surg Oncol. 2019 Jul 9. doi: 10.1002/jso.25630.
    PubMed     Abstract available


    June 2019
  118. STELZNER S, Radulova-Mauersberger O, Zschuppe E, Kittner T, et al
    Prognosis in patients with synchronous colorectal cancer metastases after complete resection of the primary tumor and the metastases.
    J Surg Oncol. 2019 Jun 5. doi: 10.1002/jso.25578.
    PubMed     Abstract available


  119. LEMOINE L, Thijssen E, Carleer R, Geboers K, et al
    Body surface area-based vs concentration-based perioperative intraperitoneal chemotherapy after optimal cytoreductive surgery in colorectal peritoneal surface malignancy treatment: COBOX trial.
    J Surg Oncol. 2019;119:999-1010.
    PubMed     Abstract available


  120. RAUSA E, Bianco F, Kelly ME, Aiolfi A, et al
    Systemic review and network meta-analysis comparing minimal surgical techniques for rectal cancer: quality of total mesorectum excision, pathological, surgical, and oncological outcomes.
    J Surg Oncol. 2019;119:987-998.
    PubMed     Abstract available


  121. MESQUITA-NETO JWB, Mouzaihem H, Macedo FIB, Heilbrun LK, et al
    Perioperative and oncological outcomes of abdominoperineal resection in the prone position vs the classic lithotomy position: A systematic review with meta-analysis.
    J Surg Oncol. 2019;119:979-986.
    PubMed     Abstract available


    May 2019
  122. KIM HS, Kim KM, Lee SB, Kim GR, et al
    Clinicopathological and biomolecular characteristics of stage IIB/IIC and stage IIIA colon cancer: Insight into the survival paradox.
    J Surg Oncol. 2019 May 27. doi: 10.1002/jso.25515.
    PubMed     Abstract available


  123. LORIMER PD, Motz BM, Kirks RC, Han Y, et al
    Frequency of unplanned surgery in patients with stage IV colorectal cancer receiving palliative chemotherapy with an intact primary: An analysis of SEER-Medicare.
    J Surg Oncol. 2019 May 18. doi: 10.1002/jso.25508.
    PubMed     Abstract available


    April 2019
  124. LINO-SILVA LS, Anchondo-Nunez P, Chit-Huerta A, Aguilar-Romero E, et al
    Stage I-III colon cancer patients with tumor deposits behave similarly to stage IV patients. Cross-section analysis of 392 patients.
    J Surg Oncol. 2019 Apr 24. doi: 10.1002/jso.25482.
    PubMed     Abstract available


  125. ANTONY P, Harnoss JC, Warschkow R, Schmied BM, et al
    Urgent surgery in colon cancer has no impact on survival.
    J Surg Oncol. 2019 Apr 12. doi: 10.1002/jso.25469.
    PubMed     Abstract available


  126. LINECKER M, Kuemmerli C, Clavien PA, Petrowsky H, et al
    Dealing with insufficient liver remnant: Associating liver partition and portal vein ligation for staged hepatectomy.
    J Surg Oncol. 2019;119:604-612.
    PubMed     Abstract available


  127. KAWAGUCHI Y, Lillemoe HA, Vauthey JN
    Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy.
    J Surg Oncol. 2019;119:594-603.
    PubMed     Abstract available


  128. KRELL RW, D'Angelica MI
    Treatment sequencing for simultaneous colorectal liver metastases.
    J Surg Oncol. 2019;119:583-593.
    PubMed     Abstract available


  129. PHILLIPS JD, Hasson RM
    Surgical management of colorectal lung metastases.
    J Surg Oncol. 2019;119:629-635.
    PubMed     Abstract available


  130. DAY RW, Aloia TA
    Enhanced recovery in liver surgery.
    J Surg Oncol. 2019;119:660-666.
    PubMed     Abstract available


  131. MARGONIS GA, Kreis ME, Wolfgang CL, Weiss MJ, et al
    Mutation status and surgical selection.
    J Surg Oncol. 2019;119:616-622.
    PubMed     Abstract available


    March 2019
  132. ENG OS, Turaga KK
    Cytoreduction and hyperthermic intraperitoneal chemotherapy in metastatic colorectal cancer.
    J Surg Oncol. 2019 Mar 10. doi: 10.1002/jso.25438.
    PubMed     Abstract available


  133. ADVANI S, Kopetz S
    Ongoing and future directions in the management of metastatic colorectal cancer: Update on clinical trials.
    J Surg Oncol. 2019 Mar 10. doi: 10.1002/jso.25441.
    PubMed     Abstract available


  134. ALZAHRANI NA, Valle SJ, Fisher OM, Sugarbaker PH, et al
    Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.
    J Surg Oncol. 2019;119:336-346.
    PubMed     Abstract available


  135. PENCOVICH N, Houli R, Lubezky N, Goykhman Y, et al
    R1 resection of colorectal liver metastasis - What is the cost of marginal resection?
    J Surg Oncol. 2019;119:347-354.
    PubMed     Abstract available


  136. CHAPMAN BC, Goodman K, Hosokawa P, Gleisner A, et al
    Improved survival in rectal cancer patients who are treated with long-course versus short-course neoadjuvant radiotherapy: A propensity-matched analysis of the NCDB.
    J Surg Oncol. 2019;119:518-531.
    PubMed     Abstract available


  137. SCLAFANI F, Hesselberg G, Thompson SR, Truskett P, et al
    Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review.
    J Surg Oncol. 2019;119:489-496.
    PubMed     Abstract available


  138. SCHLICK CJR, Merkow RP, Bentrem DJ
    Nonresectional regional therapies for metastatic colorectal cancer to the liver.
    J Surg Oncol. 2019 Mar 1. doi: 10.1002/jso.25423.
    PubMed     Abstract available


  139. VUIJK FA, Hilling DE, Mieog JSD, Vahrmeijer AL, et al
    Response to the Letter to the Editor.
    J Surg Oncol. 2019;119:399.
    PubMed    


    February 2019
  140. DE ANDRADE JP, Warner SG, Fong Y
    Treatment of metastatic colorectal cancer: innovations in surgical techniques.
    J Surg Oncol. 2019 Feb 27. doi: 10.1002/jso.25418.
    PubMed     Abstract available


  141. LEE RM, Cardona K, Russell MC
    Historical perspective: Two decades of progress in treating metastatic colorectal cancer.
    J Surg Oncol. 2019 Feb 26. doi: 10.1002/jso.25431.
    PubMed     Abstract available


  142. MELSTROM LG, Tzeng CD
    Metastatic colorectal cancer: The reality of the present and the optimism of the future.
    J Surg Oncol. 2019 Feb 26. doi: 10.1002/jso.25427.
    PubMed    


  143. SANDHU J, Lavingia V, Fakih M
    Systemic treatment for metastatic colorectal cancer in the era of precision medicine.
    J Surg Oncol. 2019 Feb 25. doi: 10.1002/jso.25421.
    PubMed     Abstract available


  144. BLISS LA, Strong EA, Gamblin TC
    Surgical resectability of multisite metastatic colorectal cancer: Pushing the limits while appropriately selecting patients.
    J Surg Oncol. 2019 Feb 25. doi: 10.1002/jso.25419.
    PubMed     Abstract available


    January 2019
  145. FLYNN SM, Burchette RJ, Ghassemi M, Ratner O, et al
    Carnoy's solution fixation with compression significantly increases the number of lymph nodes yielded from colorectal cancer specimens.
    J Surg Oncol. 2019 Jan 16. doi: 10.1002/jso.25372.
    PubMed     Abstract available


  146. LEIJSSEN LGJ, Dinaux AM, Amri R, Taylor MS, et al
    Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes.
    J Surg Oncol. 2019 Jan 15. doi: 10.1002/jso.25367.
    PubMed     Abstract available


  147. YU J, Li N, Tang Y, Wang X, et al
    Outcomes after hypofractionated stereotactic radiotherapy for colorectal cancer oligometastases.
    J Surg Oncol. 2019 Jan 4. doi: 10.1002/jso.25361.
    PubMed     Abstract available


  148. FIELDS AC, McCarty JC, Ma-Pak L, Lu P, et al
    New lymph node staging for rectal neuroendocrine tumors.
    J Surg Oncol. 2019;119:156-162.
    PubMed     Abstract available


    December 2018
  149. LINO-SILVA LS, Guzman-Lopez JC, Zepeda-Najar C, Salcedo-Hernandez RA, et al
    Overall survival of patients with colon cancer and a prolonged time to surgery.
    J Surg Oncol. 2018 Dec 24. doi: 10.1002/jso.25354.
    PubMed     Abstract available


  150. JIANG Z, Sun L, Yang W, Li J, et al
    Excessive expectations for carcinoembryonic antigen targeted fluorescent-guided surgery for sentinel lymph node detection in colorectal, pancreatic, and gastric cancer.
    J Surg Oncol. 2018 Dec 3. doi: 10.1002/jso.25318.
    PubMed    


  151. CHAKEDIS J, Beal EW, Sun S, Galo J, et al
    Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases.
    J Surg Oncol. 2018;118:1065-1073.
    PubMed     Abstract available


  152. SUAREZ J, Goicoetxea A, Gomez ML, Jimenez G, et al
    Impact of specific modes of circumferential resection margin involvement in rectal cancer local recurrence: A retrospective study.
    J Surg Oncol. 2018;118:1122-1128.
    PubMed     Abstract available


  153. REYNOLDS IS, McNamara DA, Kay EW, O'Neill B, et al
    The significance of mucin pools following neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    J Surg Oncol. 2018;118:1129-1134.
    PubMed     Abstract available


    November 2018
  154. MORIS D, Tsilimigras DI, Machairas N, Merath K, et al
    Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25313.
    PubMed     Abstract available


  155. LIAO CK, Chiang JM, Tsai WS, You JF, et al
    Primary tumor location in stage III colon cancer has prognostic impact on subsequent liver metastasis.
    J Surg Oncol. 2018 Nov 8. doi: 10.1002/jso.25270.
    PubMed     Abstract available


  156. CHOUHAN H, Sammour T, Thomas ML, Moore JW, et al
    The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
    J Surg Oncol. 2018 Nov 6. doi: 10.1002/jso.25275.
    PubMed     Abstract available


    October 2018
  157. KUMAR NAN, Verma K, Shinde RS, Kammar P, et al
    Pulmonary metastasectomy of colorectal cancer origin: Evaluating process and outcomes.
    J Surg Oncol. 2018 Oct 17. doi: 10.1002/jso.25273.
    PubMed     Abstract available


    September 2018
  158. WATANABE A, Harimoto N, Araki K, Yoshizumi T, et al
    A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25250.
    PubMed     Abstract available


  159. MARGONIS GA, Buettner S, Andreatos N, Wagner D, et al
    The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25251.
    PubMed     Abstract available


  160. VUIJK FA, Hilling DE, Mieog JSD, Vahrmeijer AL, et al
    Fluorescent-guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent-guided surgery in colorectal and pancreatic cancer.
    J Surg Oncol. 2018 Sep 14. doi: 10.1002/jso.25139.
    PubMed     Abstract available


  161. MANCEAU G, Mori A, Bardier A, Augustin J, et al
    Lymph node metastases in splenic flexure colon cancer: Is subtotal colectomy warranted?
    J Surg Oncol. 2018 Sep 13. doi: 10.1002/jso.25169.
    PubMed     Abstract available


  162. LI J, Gu J, Ma X, Li X, et al
    Development and validation of a nomogram for predicting survival in Chinese han patients with resected colorectal cancer.
    J Surg Oncol. 2018 Sep 9. doi: 10.1002/jso.25213.
    PubMed     Abstract available


  163. HU WH, Chen HH, Yen SL, Huang HY, et al
    Re: Increased expression of interleukin-23 associated with progression of colorectal cancer. Journal of Surgical Oncology 2017;115(2):208-212.
    J Surg Oncol. 2018;118:723.
    PubMed    


  164. KERANMU A, Liu HN, Wu YC, Liu TT, et al
    A negative-doughnut distal resection margin less than 5 mm does not affect prognosis in rectal cancer.
    J Surg Oncol. 2018;118:536-543.
    PubMed     Abstract available


  165. TANG Y, Rao S, Yang C, Hu Y, et al
    Value of MRI morphologic features with pT1-2 rectal cancer in determining lymph node metastasis.
    J Surg Oncol. 2018;118:544-550.
    PubMed     Abstract available


    August 2018
  166. HENTZEN JEKR, de Jongh SJ, Hemmer PHJ, van der Plas WY, et al
    Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review.
    J Surg Oncol. 2018;118:332-343.
    PubMed     Abstract available


    July 2018
  167. KRUGER JAP, Fonseca GM, Makdissi FF, Jeismann VB, et al
    Evolution in the surgical management of colorectal liver metastases: Propensity score matching analysis (PSM) on the impact of specialized multidisciplinary care across two institutional eras.
    J Surg Oncol. 2018;118:50-60.
    PubMed     Abstract available


    June 2018
  168. LE SOUDER E, Azin A, Wood T, Hirpara D, et al
    The effect of a simultaneous versus a staged resection of metastatic colorectal cancer on time to adjuvant chemotherapy.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25122.
    PubMed     Abstract available


  169. SIDERAS K, Galjart B, Vasaturo A, Pedroza-Gonzalez A, et al
    Prognostic value of intra-tumoral CD8(+) /FoxP3(+) lymphocyte ratio in patients with resected colorectal cancer liver metastasis.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25091.
    PubMed     Abstract available


  170. ZAIMI I, Sparreboom CL, Lingsma HF, Doornebosch PG, et al
    The effect of age on anastomotic leakage in colorectal cancer surgery: A population-based study.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25108.
    PubMed     Abstract available


  171. LI J, Wang Y, Liu D, Zhou H, et al
    Multidimensional analyses of the learning curve for single-incision plus one port laparoscopic surgery for sigmoid colon and upper rectal cancer.
    J Surg Oncol. 2018;117:1386-1393.
    PubMed     Abstract available


  172. FONSECA GM, de Mello ES, Faraj SF, Kruger JAP, et al
    Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases.
    J Surg Oncol. 2018;117:1364-1375.
    PubMed     Abstract available


  173. CHO MS, Park YY, Yoon J, Yang SY, et al
    MRI-based EMVI positivity predicts systemic recurrence in rectal cancer patients with a good tumor response to chemoradiotherapy followed by surgery.
    J Surg Oncol. 2018;117:1823-1832.
    PubMed     Abstract available


    May 2018
  174. CHOE EK, Yi JW, Chai YJ, Park KJ, et al
    Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to poor survival outcomes in colorectal cancer.
    J Surg Oncol. 2018 May 14. doi: 10.1002/jso.25078.
    PubMed     Abstract available


  175. DUPRE A, Rehman A, Jones RP, Parker A, et al
    Validation of clinical prognostic scores for patients treated with curative-intent for recurrent colorectal liver metastases.
    J Surg Oncol. 2018;117:1330-1336.
    PubMed     Abstract available


  176. DINAUX AM, Leijssen LGJ, Bordeianou LG, Kunitake H, et al
    Effects of local multivisceral resection for clinically locally advanced rectal cancer on long-term outcomes.
    J Surg Oncol. 2018;117:1323-1329.
    PubMed     Abstract available


    April 2018
  177. MIYAMOTO E, Chen-Yoshikawa TF, Ueshima C, Yoshizawa A, et al
    Transition of the programmed death 1 pathway from the primary colorectal cancer to its corresponding pulmonary metastasis.
    J Surg Oncol. 2018 Apr 17. doi: 10.1002/jso.25045.
    PubMed     Abstract available


  178. MARQUES MC, C Ribeiro HS, Costa WL Jr., de Jesus VHF, et al
    Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases (CLM)?
    J Surg Oncol. 2018 Apr 2. doi: 10.1002/jso.25048.
    PubMed     Abstract available


  179. ZHONG A, Tian Y, Zhang H, Lai M, et al
    DNA hydroxymethylation of colorectal primary carcinoma and its association with survival.
    J Surg Oncol. 2018;117:1029-1037.
    PubMed     Abstract available


  180. BOGACH J, Tsai S, Zbuk K, Wong R, et al
    Quality of preoperative pelvic computed tomography (CT) and magnetic resonance imaging (MRI) for rectal cancer in a region in Ontario: A retrospective population-based study.
    J Surg Oncol. 2018;117:1038-1042.
    PubMed     Abstract available


  181. JUSTINGER C, Gruden J, Kouladouros K, Stravodimos C, et al
    Histopathological changes resulting from selective internal radiotherapy (SIRT).
    J Surg Oncol. 2018;117:1084-1091.
    PubMed     Abstract available


  182. MCCLUNEY SJ, Giakoustidis A, Segler A, Bissel J, et al
    Neutrophil: Lymphocyte ratio as a method of predicting complications following hepatic resection for colorectal liver metastasis.
    J Surg Oncol. 2018;117:1058-1065.
    PubMed     Abstract available


    March 2018
  183. BAGANTE F, Spolverato G, Beal E, Merath K, et al
    Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer.
    J Surg Oncol. 2018 Mar 25. doi: 10.1002/jso.25044.
    PubMed     Abstract available


  184. CHEN ST, Wu MC, Hsu TC, Yen DW, et al
    Comparison of outcome and cost among open, laparoscopic, and robotic surgical treatments for rectal cancer: A propensity score matched analysis of nationwide inpatient sample data.
    J Surg Oncol. 2018;117:497-505.
    PubMed     Abstract available


  185. LEE SY, Kim CH, Kim YJ, Kim HR, et al
    Prognostic significance of the distribution of lymph node metastasis in rectal cancer after neoadjuvant chemoradiation.
    J Surg Oncol. 2018;117:514-522.
    PubMed     Abstract available


  186. SESHADRI RA, Swaminathan R, Srinivasan A
    Laparoscopic versus open surgery for rectal cancer after neoadjuvant chemoradiation: Long-term outcomes of a propensity score matched study.
    J Surg Oncol. 2018;117:506-513.
    PubMed     Abstract available


  187. CABELLOS OLIVARES M, Labalde Martinez M, Torralba M, Rodriguez Fraile JR, et al
    C-reactive protein as a marker of the surgical stress reduction within an ERAS protocol (Enhanced Recovery After Surgery) in colorectal surgery: A prospective cohort study.
    J Surg Oncol. 2018;117:717-724.
    PubMed     Abstract available


  188. SUN Y, Zhang Y, Wu X, Lin H, et al
    Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.
    J Surg Oncol. 2018;117:737-744.
    PubMed     Abstract available


  189. AMIKURA K, Akagi K, Ogura T, Takahashi A, et al
    The RAS mutation status predicts survival in patients undergoing hepatic resection for colorectal liver metastases: The results from a genetic analysis of all-RAS.
    J Surg Oncol. 2018;117:745-755.
    PubMed     Abstract available


  190. FISHER SB, Rafeeq S, Hess K, Grotz TE, et al
    Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC).
    J Surg Oncol. 2018;117:685-691.
    PubMed     Abstract available


  191. PAK LM, Kemeny NE, Capanu M, Chou JF, et al
    Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
    J Surg Oncol. 2018;117:634-643.
    PubMed     Abstract available


  192. IHNAT P, Slivova I, Tulinsky L, Ihnat Rudinska L, et al
    Anorectal dysfunction after laparoscopic low anterior rectal resection for rectal cancer with and without radiotherapy (manometry study).
    J Surg Oncol. 2018;117:710-716.
    PubMed     Abstract available


    February 2018
  193. LE SOUDER EB, Azin A, Hirpara DH, Walker R, et al
    Considering the cost of a simultaneous versus staged approach to resection of colorectal cancer with synchronous liver metastases in a publicly funded healthcare model.
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25020.
    PubMed     Abstract available


  194. WALKER R, Wood T, LeSouder E, Cleghorn M, et al
    Comparison of two novel staging systems with the TNM system in predicting stage III colon cancer survival.
    J Surg Oncol. 2018 Feb 23. doi: 10.1002/jso.25009.
    PubMed     Abstract available


  195. HUIJBERS A, van Pelt GW, Kerr RS, Johnstone EC, et al
    The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial.
    J Surg Oncol. 2018 Feb 15. doi: 10.1002/jso.24998.
    PubMed     Abstract available


  196. IDREES K, Padmanabhan C, Liu E, Guo Y, et al
    Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma.
    J Surg Oncol. 2018;117:284-289.
    PubMed     Abstract available


  197. GRAVANTE G, Stephenson JA, Elshaer M, Osman A, et al
    Analysis of outcomes achieved with squamous cell carcinomas of the anus in a single university hospital over the last two decades: Clinical response rate, relapse and survival of 190 patients.
    J Surg Oncol. 2018;117:269-274.
    PubMed     Abstract available


  198. TANI K, Shindoh J, Akamatsu N, Arita J, et al
    Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
    J Surg Oncol. 2018;117:191-197.
    PubMed     Abstract available


    December 2017
  199. KOZMAN MA, Fisher OM, Rebolledo BJ, Parikh R, et al
    CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
    J Surg Oncol. 2017 Dec 19. doi: 10.1002/jso.24911.
    PubMed     Abstract available


  200. IWAI T, Yamada T, Koizumi M, Shinji S, et al
    Oxaliplatin-induced increase in splenic volume; irreversible change after adjuvant FOLFOX.
    J Surg Oncol. 2017;116:947-953.
    PubMed     Abstract available


  201. GOTO S, Hida K, Kawada K, Okamura R, et al
    Multicenter analysis of transanal tube placement for prevention of anastomotic leak after low anterior resection.
    J Surg Oncol. 2017;116:989-995.
    PubMed     Abstract available


  202. MARGONIS GA, Buettner S, Andreatos N, Sasaki K, et al
    Preoperative bevacizumab and volumetric recovery after resection of colorectal liver metastases.
    J Surg Oncol. 2017;116:1150-1158.
    PubMed     Abstract available


  203. AL-NAJAMI I, Drue HC, Steele R, Baatrup G, et al
    Dual energy CT - a possible new method to assess regression of rectal cancers after neoadjuvant treatment.
    J Surg Oncol. 2017;116:984-988.
    PubMed     Abstract available


    November 2017
  204. CHOI WJ, Moon JH, Min JS, Song YK, et al
    Real-time detection system for tumor localization during minimally invasive surgery for gastric and colon cancer removal: In vivo feasibility study in a swine model.
    J Surg Oncol. 2017 Nov 28. doi: 10.1002/jso.24922.
    PubMed     Abstract available


  205. CHOE EK, Park KJ, Ryoo SB, Moon SH, et al
    The impact of visceral adipose tissue amount on the adequacy of lymph node retrieval in colorectal cancer surgery.
    J Surg Oncol. 2017 Nov 9. doi: 10.1002/jso.24876.
    PubMed     Abstract available


  206. VAN DE PUTTE D, Van Daele E, Willaert W, Pattyn P, et al
    Effect of abdominopelvic sepsis on cancer outcome in patients undergoing sphincter saving surgery for rectal cancer.
    J Surg Oncol. 2017;116:722-729.
    PubMed     Abstract available


    October 2017
  207. JOSHI HM, Keller DS, Chand M
    Utilization of Indocyanine green to demonstrate lymphatic mapping in colon cancer.
    J Surg Oncol. 2017 Oct 29. doi: 10.1002/jso.24795.
    PubMed    


  208. MANSO M, Schmelz J, Aloia T
    ERAS-Anticipated outcomes and realistic goals.
    J Surg Oncol. 2017;116:570-577.
    PubMed     Abstract available


    September 2017
  209. SASAKI K, Margonis GA, Andreatos N, Zhang XF, et al
    The prognostic utility of the "Tumor Burden Score" based on preoperative radiographic features of colorectal liver metastases.
    J Surg Oncol. 2017;116:515-523.
    PubMed     Abstract available


    May 2017
  210. LANGAN RC, Goldman DA, D'Angelica MI, DeMatteo RP, et al
    Recurrence patterns following irreversible electroporation for hepatic malignancies.
    J Surg Oncol. 2017;115:704-710.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: